Abstract

Serogroup B Neisseria meningitidis (menB) is a major cause of nonepidemic meningococcal disease in industrialized countries. Although an effective vaccine against meningococci of serogroups A, C, Y, and W-135 was developed in the 1970s, the similarity between the capsular polysaccharide of menB and …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call